US 12065506
Anti-TMPRSS2 antibodies and antigen-binding fragments
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 12065506 (Anti-TMPRSS2 antibodies and antigen-binding fragments) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 31
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K9/0019